November 2014Shandong Taibang received the approval from the Hebei Provincial Health and Family Planning Commission to build two new plasma collection stations in Hebei Province.
October 2014Shandong Taibang received manufacturing approval certificate for Human Prothrombin Complex Concentrate ("PCC") from China Food and Drug Administration (“CFDA”).
Sept 2014China Biologic increased its equity interests in Guizhou Taibang to 76.23% through purchasing additional interest from a minority shareholder.
June-July 2014China Biologic sold 920,000 shares of common stock from its treasury stock in a follow-on offering, and raised net proceeds of approximately $33.2 million.
|FirstPage | PreviousPage | NextPage | LastPage||CurrentPageIndex：1       |